Grant: Engage Grants Program
University of Manitoba
$25,000.00
Identification and quantization of biologically active flavonoids in Red Osier Dogwood bark and development of a standardized preparation for its sale as a nutraceutical
FY 2013-14
Summary
Red Dog Enterprises Inc. (Red Dog), a Manitoba based company, intends to commercialize the production,marketing and sale of an unique and highly beneficial nutraceutical supplement from Red-Osier Dogwood[Cornus seriea (Syn C. stolonifera)]. The plant had been used as a traditional medicine by Native Americaindigenous people to treat diarrhea, fever, skin problems, etc. Red Dog, in unpublished field trials hasdemonstrated that the consumption of a small amount of the plant was able to mitigate the symptoms of goutand to reduce blood pressure in hypertensive individuals. Unpublished semiquantitative data have shown thatthe plant contains several beneficial nutraceuticals including quercetin, gallic acid and ellagic acid, all of whichhave been shown by other researchers to be powerful antioxidants that are especially effective in preventingand treating cardiovascular disease, hypertension, gout, cancer, and anti-inflammatory reactions, etc. Red Dog,in order to commercialize the sale of its product, must obtain information on the concentrations of thequantitatively important compounds in its product, on methods that can be employed for their routine analysis,factors affecting the stability and shelf-life of the active components, and the development of a standardizedprocedure for the production of the supplement. The Natural Products Division of Health Canada informed RedDog that it will be possible to obtain a licence to market the product as a traditional herbal medicine, especiallyif it is shown to contain known amounts of beneficial nutraceuticals and if a standard production procedure isdeveloped. Research at the Richardson Centre for Functional Foods and Nutraceuticals (RCFFN), University ofManitoba, under the supervision of Dr. P. Jones will enable Red Dog to obtain the information required tolicence and therefore to market its product.
Program
Engage Grants Program
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
451580-2013
Name nom
Jones, Peter
Department département
Richardson Centre for Functional Foods and Nutraceuticals
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
100
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Agriculture and primary food production
Area of application fr
Agriculture et produits alimentaires primaires
Research subject code
6100
Research subject group en
Food science and technology
Research subject group fr
Science et technologie de l'alimentation
Research subject en
Food science and technology
Research subject fr
Science et technologie de l'alimentation
Partie
1
Nb partie
1
Application title
Identification and quantization of biologically active flavonoids in Red Osier Dogwood bark and development of a standardized preparation for its sale as a nutraceutical
Keyword
NSERC
Application summary
Red Dog Enterprises Inc. (Red Dog), a Manitoba based company, intends to commercialize the production,marketing and sale of an unique and highly beneficial nutraceutical supplement from Red-Osier Dogwood[Cornus seriea (Syn C. stolonifera)]. The plant had been used as a traditional medicine by Native Americaindigenous people to treat diarrhea, fever, skin problems, etc. Red Dog, in unpublished field trials hasdemonstrated that the consumption of a small amount of the plant was able to mitigate the symptoms of goutand to reduce blood pressure in hypertensive individuals. Unpublished semiquantitative data have shown thatthe plant contains several beneficial nutraceuticals including quercetin, gallic acid and ellagic acid, all of whichhave been shown by other researchers to be powerful antioxidants that are especially effective in preventingand treating cardiovascular disease, hypertension, gout, cancer, and anti-inflammatory reactions, etc. Red Dog,in order to commercialize the sale of its product, must obtain information on the concentrations of thequantitatively important compounds in its product, on methods that can be employed for their routine analysis,factors affecting the stability and shelf-life of the active components, and the development of a standardizedprocedure for the production of the supplement. The Natural Products Division of Health Canada informed RedDog that it will be possible to obtain a licence to market the product as a traditional herbal medicine, especiallyif it is shown to contain known amounts of beneficial nutraceuticals and if a standard production procedure isdeveloped. Research at the Richardson Centre for Functional Foods and Nutraceuticals (RCFFN), University ofManitoba, under the supervision of Dr. P. Jones will enable Red Dog to obtain the information required tolicence and therefore to market its product.